Business Wire

Improbable Leverages Improved Financial Profile to Drive Innovation in AI, the Metaverse, and Web3 Through Venture Building

Share

Predictions for 2025 Signal a Breakthrough Year for Virtual Economies, Interoperable Identities, and AI-Powered Gaming

Improbable, a venture builder dedicated to growing businesses across AI, the metaverse, and Web3 ecosystems, has capped off a transformative 2024 with the announcement of the profitability threshold achieved in the previous financial year, a change in business model, and significant progress across interconnected ecosystems. Central to its success is the company’s venture-building model, which has proven instrumental in creating businesses and technologies that shape the future of virtual worlds and digital economies.

Venture Building: Driving Innovation Across Ecosystems and Building the Open Metaverse

Improbable’s venture-building strategy has been key to addressing challenges and unlocking opportunities across frontier ecosystems. In 2024, the company launched several new ventures, including:

  • Kallikor, an AI-powered platform accelerating the adoption of robotics in supply chains.
  • Jitter, transforming Twitch streams into interactive multiplayer games.
  • Chamber, a next-gen platform blending the accessibility of Zoom with the immersive feel of real-world conferences, enabling businesses to host cost-effective virtual events at scale.

In 2024, MSquared, a venture of Improbable, set up the Virtual Society Foundation as an independent entity to promote openness and equity in the metaverse. The VSF’s flagship project, Somnia, is a foundational step toward a decentralized metaverse, designed to unify gaming, NFTs, and social platforms under a creator-driven, interoperable digital economy.

Somnia is a critical step in facilitating a decentralized metaverse where individuals and ventures can collaborate, share value, and contribute to a thriving virtual society,” said Herman Narula, CEO of Improbable.

Technological Advancements and Interoperable Experiences

Improbable’s tech expertise continues to drive advancements that redefine virtual worlds and digital economies:

Interoperability Breakthroughs: The MLB virtual ballpark games powered by MSquared showcased new features like voice parties and virtual shops. The season finale achieved a landmark in metaverse interoperability with seamless integration of Bored Apes into the ballpark environment.

The Somnia Blockchain: Built for the metaverse and gaming applications, Somnia is a Layer 1 EVM-compatible blockchain delivering unprecedented transaction speeds of up to 500,000 per second. This scalability supports complex, interconnected virtual worlds while significantly reducing transaction costs, making it ideal for consumer applications. Leveraging MSquared and Improbable’s technological expertise, Somnia integrates advanced protocols to facilitate interoperability between virtual environments, ensuring seamless asset and identity transfers across ecosystems.

Pioneering Experiences Across Sports, Music, and Gaming

Improbable delivered groundbreaking virtual experiences in 2024, connecting global audiences with their passions and showcasing the potential of immersive technologies:

  • MLB Virtual Ballpark: September’s MLB season redefined fan engagement with immersive features like voice parties, virtual shops, and interoperable avatars.
  • Twice KosmoPop Concert: The K-pop phenomenon Twice took center stage in KosmoPop’s virtual environment, blending music and fandom in a transformative metaverse experience.
  • Classical Meets Virtual: A metaverse-based concert with the BBC Philharmonic Orchestra brought classical music into the digital age, featuring the first motion-captured conductor.
  • The Otherside Metaverse: A continued partnership with Yuga Labs supporting their vision for The Otherside and introduced tools like the Otherside Development Kit for external creators, expanding opportunities for user-driven innovation.

Looking Ahead to 2025: Predictions for Digital Economies and Beyond

As Improbable enters 2025, the company remains focused on empowering creators, advancing technology, and fostering interconnected ecosystems across AI, the metaverse, and Web3. The company will also continue supporting the Virtual Society Foundation and Somnia for them to play pivotal roles in building a decentralized, equitable, and vibrant virtual society.

AI in Virtual Worlds: Transformative Yet Nascent

2025 will showcase AI's growing role in virtual worlds, with jaw-dropping demos like text-to-3D generation. Yet, these advancements will be hampered by the lack of high-quality datasets and the significant computational power they demand. AI agents powered by large language models will appear more frequently in games, but not yet in AAA projects. However, the disruption is coming: Asia is set to lead with multi-million-dollar budget games leveraging AI, transforming content workflows and inspiring a new wave of game development.

AI-Developed Games Will Redefine Gaming

2025 could mark the arrival of a transformative AI-developed game that becomes an industry touchstone. Expect to see the first examples of games integrating AI not just into gameplay but as the foundation of development itself. These titles will revolutionize workflows and inspire the next generation of game creators.

Web3 Gains Ground with Programmatic Economies

The gaming industry will explore Web3 beyond NFTs, tapping into blockchain’s potential for robust in-game economies. Titles like Off the Grid have already shown how blockchain-backed economies can integrate seamlessly into games without feeling "scammy". This trend signals a growing sophistication in how Web3 is applied to gaming, sidestepping early criticisms.

Interoperable Identities: The Key to a Connected Metaverse

The quest for a universal digital identity will take center stage. Much like signing in with Google, users should be able to bring their profile pictures, 3D avatars, and other elements of their digital identity across platforms. Expect to see Bluesky-like initiatives and the beginnings of standardized protocols to make interoperable identities a reality.

Blockchain Beyond Economy: A Tool for Simulation

Blockchain is set to demonstrate its value not only as a mechanism for economic opportunities but also as a powerful simulation tool for expansive, moddable worlds. Games like EVE Online hint at this potential, showcasing how autonomous worlds and player-driven mods can push the boundaries of game development. Additionally, high-performance blockchain systems designed for gaming and the Metaverse, such as Somnia, capable of achieving transaction rates of over 400,000 per second, will further enable these expansive worlds and their interconnected economies.

At Improbable, we’re rethinking our innovation approach by investing into early-stage ventures. Our goal is to empower talented teams to operate independently while leveraging our deep expertise in AI, Web3, and the metaverse. This approach enables us to build scalable, high-impact ventures that drive meaningful change while maintaining financial sustainability”, said Herman Narula, CEO of Improbable.

https://www.improbable.io/Ventures

Improbable is a venture builder that has been at the forefront of building virtual worlds for over a decade. We incept and grow businesses in AI, Web3 and the Metaverse, to venture into new worlds.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250122022254/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press release

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in

Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press release

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration

Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press release

Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release

First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye